Nurse Practitioner in Sugar Hill, GA Accepting Medicare
8 Nurse Practitioner nurses found. Showing 1 - 8
 Mrs. Teresa Nicole Workman, FNP-C Nurse Practitioner - Family Medicare: Accepting Medicare Assignments Practice Location: 6001 Cumming Hwy, 1, Sugar Hill, GA 30518 Phone: 678-546-4062 |
Mrs. Cristiane Lemos Fukuda, NP Nurse Practitioner - Adult Health Medicare: Not Enrolled in Medicare Practice Location: 5212 Pine Branch Cir, Sugar Hill, GA 30518 Phone: 678-978-4801 |
Mrs. Michelle Davis Johnson, FNP-C Nurse Practitioner - Family Medicare: Not Enrolled in Medicare Practice Location: 6001 Cumming Hwy, Sugar Hill, GA 30518 Phone: 678-546-4062 |
Angana Fofandi, FNP Nurse Practitioner - Family Medicare: Not Enrolled in Medicare Practice Location: 590 Fulper Ct, Sugar Hill, GA 30518 Phone: 678-889-7922 |
Ms. Melissa Sharon Chason, F.N.P. Nurse Practitioner - Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 110 Peachtree Industrial Blvd Ste A, Sugar Hill, GA 30518 Phone: 678-765-8622 Fax: 678-765-8621 |
Alcyonita Montgomery, Nurse Practitioner - Family Medicare: Medicare Enrolled Practice Location: 6001 Cumming Hwy, Sugar Hill, GA 30518 Phone: 678-546-4062 |
Ms. Maya Dockery Leines, FNP Nurse Practitioner - Family Medicare: Medicare Enrolled Practice Location: 6001 Cumming Hwy, Sugar Hill, GA 30518 Phone: 678-546-4062 |
Lela Sandiford, ARNP Nurse Practitioner - Adult Health Medicare: Not Enrolled in Medicare Practice Location: 5910 Suwanee Dam Rd Ste 200, Sugar Hill, GA 30518 Phone: 678-714-3053 |
News Archive
Daily moderate drinking may decrease atherosclerosis
For the first time, new research shows that patterns of alcohol consumption - a drink or two every night, or several cocktails on Friday and Saturday nights only - may be more important in determining alcohol's influence on heart health than the total amount consumed.
Scientists lay out a novel rationale for COVID-19 drug design
American and Polish scientists, reporting Oct. 16 in the journal Science Advances, laid out a novel rationale for COVID-19 drug design - blocking a molecular "scissor" that the virus uses for virus production and to disable human proteins crucial to the immune response.
New approach harnesses disease-causing proteins to combat cancer
Over many decades now, traditional drug discovery methods have steadily improved at keeping diseases at bay and cancer in remission. And for the most part, it's worked well.
Ironwood Pharmaceuticals' IPO: Underwriters exercise over-allotment option
Ironwood Pharmaceuticals, Inc. today announced that the underwriters of its February 2, 2010 initial public offering (IPO) have exercised their over-allotment option in full on an additional 2.5 million shares of Ironwood's Class A common stock. With the completion of the IPO and the exercise of the over-allotment option, Ironwood has approximately 97.4 million shares of common stock outstanding (approximately 19.2 million shares of Class A common stock and 78.2 million shares of Class B common stock).
› Verified 3 days ago